Literature DB >> 19998321

Breath carbon monoxide and semiquantitative saliva cotinine as biomarkers for smoking.

Gina F Marrone1, Mane Paulpillai, Rebecca J Evans, Edward G Singleton, Stephen J Heishman.   

Abstract

OBJECTIVE: As a biomarker of smoking, semiquantitative analysis of cotinine (NicAlert) offers several advantages over breath carbon monoxide (CO) and quantitative analysis of cotinine. Recent studies have used urine NicAlert and breath CO in combination to verify abstinence. However, no studies have evaluated the performance of saliva NicAlert against or in combination with breath CO.
METHOD: Breath CO, saliva NicAlert, and smoking history were compared in an urban population of daily smokers (n = 24) and nonsmokers (n = 25).
RESULTS: Saliva NicAlert predicted self-reported smoking with 100% sensitivity and 96% specificity. At a cutoff of > 5 ppm, breath CO had 100% sensitivity and 100% specificity in predicting self-reported smoking. Breath CO was positively correlated with saliva NicAlert and negatively correlated with minutes since last cigarette.
CONCLUSION: Saliva NicAlert had high sensitivity and specificity in identifying daily smokers. Compared to saliva NicAlert, breath CO level was more indicative of recent smoking. Future treatment studies should evaluate the performance of saliva NicAlert as an alternative to the urine test.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19998321      PMCID: PMC2805052          DOI: 10.1002/hup.1078

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  19 in total

1.  Biochemical verification of tobacco use and cessation.

Authors: 
Journal:  Nicotine Tob Res       Date:  2002-05       Impact factor: 4.244

2.  Basic principles of ROC analysis.

Authors:  C E Metz
Journal:  Semin Nucl Med       Date:  1978-10       Impact factor: 4.446

3.  Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates.

Authors:  Martin J Jarvis; Paola Primatesta; Bob Erens; Colin Feyerabend; Andrew Bryant
Journal:  Nicotine Tob Res       Date:  2003-06       Impact factor: 4.244

4.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

5.  Considerations of the physiological variables that determine the blood carboxyhemoglobin concentration in man.

Authors:  R F Coburn; R E Forster; P B Kane
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

Review 6.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Authors:  M H Zweig; G Campbell
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

7.  Measurement and estimation of smoke dosage to non-smokers from environmental tobacco smoke.

Authors:  M J Jarvis; M A Russell
Journal:  Eur J Respir Dis Suppl       Date:  1984

8.  Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison.

Authors:  Karen L Cropsey; Gloria D Eldridge; Michael F Weaver; Gabriela C Villalobos; Maxine L Stitzer
Journal:  Nicotine Tob Res       Date:  2006-10       Impact factor: 4.244

9.  Nicotine metabolism and intake in black and white smokers.

Authors:  E J Pérez-Stable; B Herrera; P Jacob; N L Benowitz
Journal:  JAMA       Date:  1998-07-08       Impact factor: 56.272

10.  Smoking and nicotine dependence in young adults: differences between blacks and whites.

Authors:  P Andreski; N Breslau
Journal:  Drug Alcohol Depend       Date:  1993-04       Impact factor: 4.492

View more
  34 in total

1.  Response to nicotine following overnight smoking abstinence during short-term progesterone treatment in women.

Authors:  Sharon Allen; Ashley Petersen; Katherine Harrison; Nicole Tosun; Jacquelyn Cameron
Journal:  Exp Clin Psychopharmacol       Date:  2019-08-29       Impact factor: 3.157

2.  Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers.

Authors:  Marcel A de Dios; Bradley J Anderson; Cassandra Stanton; Daniel A Audet; Michael Stein
Journal:  J Subst Abuse Treat       Date:  2012-02-27

3.  Emotional reactivity to emotional and smoking cues during smoking abstinence: potentiated startle and P300 suppression.

Authors:  Jeffery M Engelmann; Jonathan C Gewirtz; Bruce N Cuthbert
Journal:  Psychophysiology       Date:  2011-12       Impact factor: 4.016

4.  Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.

Authors:  Marlon P Mundt; Timothy B Baker; David L Fraser; Stevens S Smith; Megan E Piper; Michael C Fiore
Journal:  Value Health       Date:  2018-09-20       Impact factor: 5.725

5.  Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial.

Authors:  Kathryn L Taylor; Danielle E Deros; Shelby Fallon; Jennifer Stephens; Emily Kim; Tania Lobo; Kimberly M Davis; George Luta; Jinani Jayasekera; Rafael Meza; Cassandra A Stanton; Raymond S Niaura; David B Abrams; Brady McKee; Judith Howell; Michael Ramsaier; Juan Batlle; Ellen Dornelas; Vicky Parikh; Eric Anderson
Journal:  Contemp Clin Trials       Date:  2019-05-23       Impact factor: 2.226

6.  Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.

Authors:  Lisa R LaRowe; Jesse D Kosiba; Emily L Zale; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2018-07-23       Impact factor: 3.157

7.  Optimal Carbon Monoxide Criteria to Confirm Smoking Status Among Postpartum Women.

Authors:  Rebecca L Emery; Michele D Levine
Journal:  Nicotine Tob Res       Date:  2015-09-18       Impact factor: 4.244

8.  Exogenous progesterone for smoking cessation in men and women: a pilot double-blind, placebo-controlled randomized clinical trial.

Authors:  Nicole L Tosun; Ann M Fieberg; Lynn E Eberly; Katherine A Harrison; Angela R Tipp; Alicia M Allen; Sharon S Allen
Journal:  Addiction       Date:  2019-06-17       Impact factor: 6.526

9.  Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.

Authors:  A Joseph Bloom; Timothy B Baker; Li-Shiun Chen; Naomi Breslau; Dorothy Hatsukami; Laura J Bierut; Alison Goate
Journal:  Hum Mol Genet       Date:  2013-09-17       Impact factor: 6.150

10.  Salivary stress biomarkers of recent nicotine use and dependence.

Authors:  Matthew C Morris; Alyssa S Mielock; Uma Rao
Journal:  Am J Drug Alcohol Abuse       Date:  2016-07-27       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.